Seroprevalence Brazil.
| Autor: | Fialho PMM; Institute of Medical Sociology, Centre for Health and Society, Medical Faculty, University of Duesseldorf, Duesseldorf, Germany. Electronic address: paulamayara.matosfialho@med.uni-duesseldorf.de., Correa CRS; Departamento de Saúde Coletiva, Faculdade de Ciências Médicas, São Paulo, Brazil., Lescano SZ; Universidade de São Paulo, Instituto de Medicina Tropical de São Paulo-FMUSP, Laboratório de Imunopatologia da Esquistossomose, São Paulo, Brazil. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Advances in parasitology [Adv Parasitol] 2020; Vol. 109, pp. 357-374. Date of Electronic Publication: 2020 Jan 31. |
| DOI: | 10.1016/bs.apar.2020.01.013 |
| Abstrakt: | This chapter presents an overview of the seroprevalence of toxocariasis in Brazil and discusses how this zoonosis is studied, diagnosed, and treated in the Brazilian population. Toxocariasis in humans has a high prevalence in several regions of Brazil; however, this disease is neglected because of lack of knowledge, non-specific clinical signs, and difficult diagnosis. Most studies conducted in Brazil have estimated the prevalence of toxocariasis, i.e., the number of people who presented the disease at any given time. However, a few studies have determined disease incidence (number of new cases in a population at risk) and identified risk factors for Toxocara canis infection. Despite the high seroprevalence, the Brazilian population is not well aware of toxocariasis. Thus, the need of the hour is to raise awareness about this parasitic infection because of its worldwide distribution and potential health risk. (© 2020 Elsevier Ltd All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|